Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexes, and study the extent and the mode of their antiproliferative activity on HeLa cells. Six platinum(II) isomer pairs have a general formula cis-/trans-[PtA(2) X-2] where A is ligand: ammonia (NH3), pyridine (Py); and X is ligand: chloride ion (Cl-), bromide ion (Br-), iodide ion (I-), thiocyanato, ion (SCN-); four compounds have different structural formulas, and these are cis-/trans-[Pt(NH2OH)(2) (NH3)(2)]Cl-2, and cis-/trans- Pt(Gly)(2), where Gly is bidentate glycinato ligand. Results of the MTT assay, showed that six cis- and one trans-platinum(II) complexes exhibited cytotoxicity (IC50) ranging between 5 and 33 muM. Most of the cis-plat...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexe...
Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexe...
Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexe...
Wide range of dose-limiting toxicities and tumor resistance to drug are significant limitations of t...
Wide range of dose-limiting toxicities and tumor resistance to drug are significant limitations of t...
The major interest in platinum(II) complexes as anticancer drugs is still centered at present on squ...
The major interest in platinum(II) complexes as anticancer drugs is still centered at present on squ...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
A new platinum(II) complex containing a pyridine nucleus and a dithiocarbamate moiety as ligands ([P...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexe...
Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexe...
Purpose of this work was to synthesize several cis-/trans- isomer pairs of the platinum(II) complexe...
Wide range of dose-limiting toxicities and tumor resistance to drug are significant limitations of t...
Wide range of dose-limiting toxicities and tumor resistance to drug are significant limitations of t...
The major interest in platinum(II) complexes as anticancer drugs is still centered at present on squ...
The major interest in platinum(II) complexes as anticancer drugs is still centered at present on squ...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
A new platinum(II) complex containing a pyridine nucleus and a dithiocarbamate moiety as ligands ([P...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
Six diiodido-diamine platinum(II) complexes, either cis or trans configured, were prepared, differin...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...